Health Adjuvant Nivolumab Promising in Resected Merkel Cell Carcinoma Eli Pacheco Jul 15, 2023 0 Adjuvant therapy with nivolumab (Opdivo) was feasible and safe and appeared to prolong disease-free survival (DFS)…
Health Adjuvant Osimertinib as a Standard Therapy for EGFR-Positive NSCLC Eli Pacheco Jul 7, 2023 0 Treatment with osimertinib (Tagrisso) after surgery significantly reduced the risk of death…
Health Adjuvant Immunotherapy in Early-Stage NSCLC Eli Pacheco Jun 29, 2023 0 Adjuvant chemotherapy has been the standard of care for patients with resectable non-small…
Health Adjuvant Ribociclib Cuts Recurrence in Early-Stage Breast Cancer Eli Pacheco Jun 13, 2023 0 Adding ribociclib (Kisqali) to endocrine therapy led to a significant improvement in invasive…
Health Adjuvant CRT Yields No Survival Benefit in Advanced Endometrial Cancer Eli Pacheco May 5, 2023 0 The long-running randomized NRG Oncology GOG-258 trial failed to identify an overall survival (OS) benefit…
Health Adjuvant Combo May Change Practice in High-Risk Liver Cancer Eli Pacheco Apr 18, 2023 0 ORLANDO -- For the first time, adjuvant therapy has improved recurrence-free survival (RFS) after surgery or ablation for…
Health Updated Results on Adjuvant Immunotherapy in Muscle-Invasive Bladder Cancer Eli Pacheco Mar 7, 2023 0 In this exclusive roundtable video from MedPage Today, three expert leaders in the field of bladder cancer…
Health Adjuvant Therapy Recommendations for Breast Cancer Drop Between Ages 69 and 70 Eli Pacheco Feb 4, 2023 0 Elana Gotkine FRIDAY, Feb. 3, 2023 (HealthDay News) -- Between ages 69 and 70 years, there is a decline in adjuvant therapy recommendations for early…
Health FDA OKs Adjuvant Pembrolizumab for NSCLC Eli Pacheco Jan 28, 2023 0 The FDA has approved pembrolizumab (Keytruda) as an adjuvant therapy following surgical…
Health Everolimus Fails Again as Adjuvant Therapy for High-Risk Breast Cancer Eli Pacheco Dec 9, 2022 0 SAN ANTONIO -- A second randomized trial failed to show a benefit of adding everolimus (Afinitor) to adjuvant endocrine therapy…